Chavers Blanche, Najarian John S, Humar Abhinav
Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.
Pediatr Transplant. 2007 Nov;11(7):702-8. doi: 10.1111/j.1399-3046.2007.00768.x.
Transplantation is now the preferred treatment for children with end-stage kidney disease. But not all pediatric age groups have enjoyed the same success. The number of transplants in infants and young children has lagged behind the number in older children. One reason for this is the philosophy of some centers to maintain infants on dialysis until they reach some arbitrarily determined age, at which time they would undergo a transplant. If kidney transplantation is the therapy of choice for older children with renal failure, and equivalent results can be obtained in all age groups, why should it not be offered to these youngest patients? Our center's philosophy for many years has been not to restrict transplant based on size or age. We have performed over 50 kidney transplants in infant recipients, and have shown equivalent results to those obtained in older children. Important factors in obtaining a successful outcome include the use of adult kidneys from a living donor, careful attention to operative and perioperative care, and performing the transplant early or in a preemptive fashion. The latter allows for minimizing the negative impact of uremia on physical and neurologic development in infants.
目前,移植是终末期肾病患儿的首选治疗方法。但并非所有儿童年龄组都取得了同样的成功。婴幼儿的移植数量落后于大龄儿童。造成这种情况的一个原因是,一些中心的理念是让婴儿接受透析,直到他们达到某个任意确定的年龄,然后再进行移植。如果肾移植是大龄肾衰竭儿童的首选治疗方法,并且在所有年龄组都能获得相同的结果,那么为什么不将其提供给这些最小的患者呢?多年来,我们中心的理念一直是不根据体型或年龄限制移植。我们已经为婴儿受者进行了50多次肾移植,并显示出与大龄儿童相同的结果。获得成功结果的重要因素包括使用来自活体供体的成人肾脏、密切关注手术和围手术期护理,以及尽早或以抢先方式进行移植。后者有助于将尿毒症对婴儿身体和神经发育的负面影响降至最低。